Masaya Hattori
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Surgery top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Hiroji IwataArthur S. SchneiderGeorge S. EisenbarthHiroshi IkegamiMasataka SawakiAkiyo YoshimuraTakashi NambaHaruru Kotani
- Topics
- Breast Cancer Treatment Studies (28 papers)HER2/EGFR in Cancer Research (27 papers)Cancer Treatment and Pharmacology (22 papers)
- Journals
- New England Journal of MedicineJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Masaya Hattori
110 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 129
- Oncology 529
- Cancer Research 373
- Molecular Biology 361
- Surgery 289
- Pulmonary and Respiratory Medicine 233
Countries citing papers authored by Masaya Hattori
This map shows the geographic impact of Masaya Hattori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Hattori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Hattori more than expected).
Fields of papers citing papers by Masaya Hattori
This network shows the impact of papers produced by Masaya Hattori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Hattori. The network helps show where Masaya Hattori may publish in the future.
Co-authorship network of co-authors of Masaya Hattori
This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Hattori. A scholar is included among the top collaborators of Masaya Hattori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Hattori. Masaya Hattori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 19 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 8 | |
| 10 | 0 | |
| 11 | [A Phase I Combination Dose-Escalation Study of Eribulin Mesylate and Gemcitabine in Japanese Patients with Metastatic Breast Cancer]. | 1 |
| 12 | 1 | |
| 13 | 21 | |
| 14 | 10 | |
| 15 | [Clinical efficacy and safety assessment of eribulin monotherapy in patients with metastatic breast cancer - a single- institute experience]. | 3 |
| 16 | Three new saponins from the root bark of Aralia elata (Miq.) Seem. | 2 |
| 17 | Low expression of AGE-receptor-1 in NOD mouse mesangial cells: Possible link to diabetic nephropathy. | 6 |
| 18 | 105 | |
| 19 | 6 | |
| 20 | BASIC PROPERTIES OF HIGH STRENGTH RAIL STEELS AND NEW RAIL DEVELOPMENT | 3 |
About Masaya Hattori
Masaya Hattori is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 120 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (27 papers) and Cancer Treatment and Pharmacology (22 papers). The work is most often cited by research in Cancer Research (373 citations), Oncology (529 citations) and Endocrinology, Diabetes and Metabolism (162 citations). Masaya Hattori has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Hiroji Iwata, Arthur S. Schneider, George S. Eisenbarth, Hiroshi Ikegami, Masataka Sawaki, Akiyo Yoshimura, Takashi Namba, Haruru Kotani, Yayoi Adachi and Takio Kurita. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.